Kedudukan dalam Saham
#20667
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Harga Saham
$22.52
Disegerakkan terakhir: 2026-08-21
Perubahan (1 hari)
-1.11%
Perubahan (1 tahun)
-21.94%
Perdagangan Bioceltix S.a. (BCX)
Harga BCX dengan permodalan pasaran b
Modal pasaran bagi Bioceltix S.a.(BCX)
Modal Pasaran: $124.60M
Sehingga August 2026, Bioceltix S.a. mempunyai modal pasaran sebanyak $124.60M. Ini menjadikan Bioceltix S.a. syarikat ke-20667th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Bioceltix S.a. dari 2021 hingga 2026
BCX berbanding dengan 5 teratas yang paling popular stocks
| Harga BCX |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.211T
|
+4,182,539.58%
|
|
|
|
|
$4.547T
|
+3,649,113.88%
|
|
|
|
|
$4.162T
|
+3,340,699.14%
|
|
|
|
|
$3.593T
|
+2,883,470.32%
|
|
|
|
|
$2.793T
|
+2,241,442.15%
|
